國立虎尾科技大學 |

Phage Therapy: A Practical Approach

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Phage Therapy: A Practical Approach/ edited by Andrzej Górski, Ryszard Międzybrodzki, Jan Borysowski.
other author:	Górski, Andrzej.
Description:	XV, 385 p. 26 illus., 24 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Medical microbiology. -
Online resource:	https://doi.org/10.1007/978-3-030-26736-0
ISBN:	9783030267360

Phage Therapy: A Practical Approach
Phage Therapy: A Practical Approach[electronic resource] /edited by Andrzej Górski, Ryszard Międzybrodzki, Jan Borysowski. - 1st ed. 2019. - XV, 385 p. 26 illus., 24 illus. in color.online resource.

Part I: Bacteriophages as antibacterialagents -- Chapter 1:Production of PhageTherapeutics and Formulations – InnovativeApproaches -- Chapter 2:Phagepharmacokinetics: relationship with administrationroute -- Chapter 3:BacterialResistance to Phage and itsImpact on Clinical Therapy -- Part II: Bacteriophages and the immune system -- Chapter 4:Phageinteraction with the mammalianimmune system -- Chapter 5:Humoralimmuneresponse to phage-basedtherapeutics -- Part III:Use of bacteriophages to combat bacterial infections -- Chapter 6:How to achieve a goodphage therapy clinical trial? -- Chapter 7: Perspectives on the RenewedInterest in the United States -- Chapter 8:Phage Therapy in Orthopaedic Implant-associated Infections -- Chapter 9:The use of bacteriophages in animalhealth and food protection -- Chapter 10:Combiningbacteriophages with otherantibacterialagents to combatbacteria -- Chapter 11: Phage therapy of infectious biofilms: Challenges and strategies -- Part IV:Phage therapy – regulatory and ethical aspects -- Chapter 12:Regulatory Considerations for Bacteriophage Therapy Products -- Chapter 13:Developing phagesintomedicines for Europe -- Chapter 14: Phagetherapy in Europe: Regulatory and intellectualpropertyprotectionissues -- Chapter 15:Ethics of phagetherapy -- Part V: Bacteriophage-derived antibacterial agents -- Chapter 16: NovelAlternative to Antibiotics.

This book gives a detailed yet clear insight into the current state of the art of the therapeutic application of bacteriophages in different conditions. The authors bring in their practical expertise within their respective fields of expertise and provide an excellent overview of the potential and actual use of phage therapy. Topics like economic feasibility compared to traditional antibiotics and also regulatory issues are discussed in far detail. This new volume is therefore a valuable resource for individuals engaged in the medical application of novel phage therapies.

ISBN: 9783030267360

Standard No.: 10.1007/978-3-030-26736-0doiSubjects--Topical Terms:

583124
Medical microbiology.

LC Class. No.: QR46

Dewey Class. No.: 616.9041

Phage Therapy: A Practical Approach
LDR:03359nam a22003975i 4500 001 1004904
003 DE-He213
005 20200702225240.0
007 cr nn 008mamaa
008 210106s2019 gw | s |||| 0|eng d
020 $a 9783030267360 $9 978-3-030-26736-0
024 7 $a 10.1007/978-3-030-26736-0 $2 doi
035 $a 978-3-030-26736-0
050 4 $a QR46
072 7 $a MMFM $2 bicssc
072 7 $a MED052000 $2 bisacsh
072 7 $a MKFM $2 thema
082 0 4 $a 616.9041 $2 23
245 1 0 $a Phage Therapy: A Practical Approach $h [electronic resource] / $c edited by Andrzej Górski, Ryszard Międzybrodzki, Jan Borysowski.
250 $a 1st ed. 2019.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a XV, 385 p. 26 illus., 24 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Part I: Bacteriophages as antibacterialagents -- Chapter 1:Production of PhageTherapeutics and Formulations – InnovativeApproaches -- Chapter 2:Phagepharmacokinetics: relationship with administrationroute -- Chapter 3:BacterialResistance to Phage and itsImpact on Clinical Therapy -- Part II: Bacteriophages and the immune system -- Chapter 4:Phageinteraction with the mammalianimmune system -- Chapter 5:Humoralimmuneresponse to phage-basedtherapeutics -- Part III:Use of bacteriophages to combat bacterial infections -- Chapter 6:How to achieve a goodphage therapy clinical trial? -- Chapter 7: Perspectives on the RenewedInterest in the United States -- Chapter 8:Phage Therapy in Orthopaedic Implant-associated Infections -- Chapter 9:The use of bacteriophages in animalhealth and food protection -- Chapter 10:Combiningbacteriophages with otherantibacterialagents to combatbacteria -- Chapter 11: Phage therapy of infectious biofilms: Challenges and strategies -- Part IV:Phage therapy – regulatory and ethical aspects -- Chapter 12:Regulatory Considerations for Bacteriophage Therapy Products -- Chapter 13:Developing phagesintomedicines for Europe -- Chapter 14: Phagetherapy in Europe: Regulatory and intellectualpropertyprotectionissues -- Chapter 15:Ethics of phagetherapy -- Part V: Bacteriophage-derived antibacterial agents -- Chapter 16: NovelAlternative to Antibiotics.
520 $a This book gives a detailed yet clear insight into the current state of the art of the therapeutic application of bacteriophages in different conditions. The authors bring in their practical expertise within their respective fields of expertise and provide an excellent overview of the potential and actual use of phage therapy. Topics like economic feasibility compared to traditional antibiotics and also regulatory issues are discussed in far detail. This new volume is therefore a valuable resource for individuals engaged in the medical application of novel phage therapies.
650 0 $a Medical microbiology. $3 583124
650 0 $a Molecular biology. $3 583443
650 1 4 $a Medical Microbiology. $3 668401
650 2 4 $a Molecular Medicine. $3 668353
700 1 $a Górski, Andrzej. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1298405
700 1 $a Międzybrodzki, Ryszard. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1298406
700 1 $a Borysowski, Jan. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1298407
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030267353
776 0 8 $i Printed edition: $z 9783030267377
776 0 8 $i Printed edition: $z 9783030267384
856 4 0 $u https://doi.org/10.1007/978-3-030-26736-0
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)